← Leaderboards
Maryam Fouladi
St. Jude Children'S Research Hospital
$5,345,905
Attributed
$10,106,270
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.2M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,137,539 · 2
FDA$3,968,731 · 2
By mechanism
UM1$5,552,000 · 1
R01$3,968,731 · 2
R21$585,539 · 1
Top collaborators
- Rachid Drissi5 shared
- James M Boyett1 shared
- Margot Lazow1 shared
- Arzu Onar-Thomas1 shared
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Suzanne J Baker$15,879,154
- Richard James Gilbertson$38,555,720
- James M Boyett$5,624,863
- Paul Northcott$7,792,208
- Stephen C Mack$5,806,636
Others in their field
Top investigators on “Enrollment”
- Jeffrey P Krischer · University Of South Florida$370,021,822
- Lawrence Corey · Fred Hutchinson Cancer Center$329,293,433
- David R. Weir · University Of Michigan At Ann Arbor$265,368,888
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$231,949,330
- James Dennis Neaton · Northwestern University$218,104,551
- George R Seage · Abt Associates, Inc.$205,403,788
Research focus
EnrollmentEpendymomaBiological PreservationAntibodiesBiologicalCancer EtiologyCancer Trials Support UnitCancer VaccinesBiologyBaseBrain NeoplasmsCharacteristicsChildChildhoodChildhood Brain NeoplasmChildhood Central Nervous System NeoplasmClinical TrialsCollaborationsCentral Nervous System DiseasesDiffuseDisorder ControlCentral Nervous System NeoplasmsCessation Of LifeFace
Grant awards (10)
Phase II, Multi-arm, Molecularly-Guided Umbrella Trial for Children and Young Adults with High-Grade Glioma$3,218,733
R01 · FY2025 · FD · contact PI
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas$250,000
R01 · FY2022 · FD · contact PI
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas$249,999
R01 · FY2021 · FD · contact PI
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas$119,741
R01 · FY2020 · FD · contact PI
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas$77,591
R01 · FY2019 · FD · contact PI
IND:138100. A phase I and surgical cohort Study of PTC596 in newly diagnosed children with DIPG and high-grade gliomas$52,667
R01 · FY2019 · FD · contact PI
Pediatric Brain Tumor Consortium (PBTC)$2,726,546
UM1 · FY2015 · CA
Pediatric Brain Tumor Consortium (PBTC)$2,825,454
UM1 · FY2014 · CA
Lapatinib in childhood CNS malignancies$289,289
R21 · FY2006 · CA · contact PI
Lapatinib in childhood CNS malignancies$296,250
R21 · FY2005 · CA